NTAGI panel recommends use of Covid vaccines Corbevax, Covaxin for kids aged 5-12 years

The members, however, opined that data of Covid burden and mortality among children is not robust enough to take any decision to begin vaccination of those below 12 years, an official source said.

(Representational Image)

The NTAGI’s Standing Technical Sub-Committee (STSC) approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday.

However, there was no decision on introducing these vaccines in the vaccination programme.

Data of Biological E’s Corbevax and Bharat Biotech’s Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16 and members decided that the vaccines can be recommended for administering in children.

Story continues below this ad

The members, however, opined that data of Covid burden and mortality among children is not robust enough to take any decision to begin vaccination of those below 12 years, an official source said.

The issue is likely to be discussed in the next meeting.

India’s drug regulator in April this year had granted emergency use authorisation to Corbevax for those aged five to 12 years and Covaxin for children in the age group of six to 12 years.

Stay updated with the latest - Click here to follow us on Instagram

You May Like

Nepal Army chief steps in, ex-Chief Justice agrees to be interim head

World6 hr ago

General Ashok Raj Sigdel successfully convinced former Chief Justice Sushila Karki to become the interim Chief Executive after violent protests led to the fall of the K P Sharma Oli government. He held talks with various groups and proposed an interim government to restore peace. Karki, with the support of the Nepal Army, will work towards delivering a new Constitution.

View all shorts

Live Blog